If you’ve been diagnosed with chronic myelomonocytic leukemia (CMML), your treatment team will discuss your options with you. It’s important to weigh the benefits of each treatment option against the possible risks and side effects.

2017年7月13日 · Except for allogeneic stem cell transplantation (ASCT), there is no disease-modifying treatment in CMML. Current therapies aim to improve symptom burden using a personalized strategy guided by cytopenia-induced or proliferation-associated symptoms.

CMML Treatment Options. Our physicians are part of a multidisciplinary leukemia treatment team whose approach to cancer and blood disorders is to personalize the treatment plan for each patient and to treat them holistically, focusing on the whole person and not just on their disease.

2024年9月18日 · Pretreatment evaluation of the patient with chronic myelomonocytic leukemia (CMML) identifies disease-associated symptoms, assesses medical fitness, and evaluates comorbid illnesses to aid selection of a management strategy. Clinical features, initial evaluation and diagnosis, and differential diagnosis of CMML are discussed separately.

Types of CMML Treatment. In most cases, CMML can't be cured, but it can be treated. Doctors use several types of treatment for adults with CMML, although there's no one standard drug therapy for the disease: Chemotherapy and drug therapy; Stem cell transplantation; Clinical trials ; Finding the Best Treatment Approach. For most CMML patients ...

Treatment of CMML depends on how severe the disease is, as well as the patient’s age and health. Treatment options include: Supportive care with blood transfusions, growth factors and antibiotics to treat symptoms by increasing blood counts and stopping infections; Chemotherapy to kill cells cancer cells using cytotoxic agents

2017年3月1日 · New treatments for CMML and JMML, including approaches that target chromosomal and DNA mutations, are being researched in clinical trials. CMML and JMML are uncommon blood cancers that have overlapping features of two other types of blood cancers: myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs).

Response rate to treatments ranges from 40% to 50%. 90% of CMML cases result from specific genetic mutations (changes). Between 15-30% of CMML cases transform into acute myeloid leukemia. Around 10% of CMML-2 patients and 20% of CMML-1 …

Chronic myelomonocytic leukaemia (CMML) is a rare type of leukaemia characterised by increased levels of monocyte white blood cells, as well as features from the myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs).

4 天之前 · Researchers are continuing to explore new treatment options for chronic myeloid leukemia. ... IMM01+azacitidine VS placebo +azacitidine in patients with newly diagnosed chronic myelomonocytic ...